A citation-based method for searching scientific literature

Hind Mehel, Julius Emons, Christiane Vettel, Katrin Wittköpper, Danilo Seppelt, Matthias Dewenter, Susanne Lutz, Samuel Sossalla, Lars S Maier, Patrick Lechêne, Jérôme Leroy, Florence Lefebvre, Audrey Varin, Thomas Eschenhagen, Stanley Nattel, Dobromir Dobrev, Wolfram-Hubertus Zimmermann, Viacheslav O Nikolaev, Grégoire Vandecasteele, Rodolphe Fischmeister, Ali El-Armouche. J Am Coll Cardiol 2013
Times Cited: 79







List of co-cited articles
1090 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway.
Marco Mongillo, Carlo G Tocchetti, Anna Terrin, Valentina Lissandron, York-Fong Cheung, Wolfgang R Dostmann, Tullio Pozzan, David A Kass, Nazareno Paolocci, Miles D Houslay,[...]. Circ Res 2006
201
44

Cardiac Hypertrophy Is Inhibited by a Local Pool of cAMP Regulated by Phosphodiesterase 2.
Anna Zoccarato, Nicoletta C Surdo, Jan M Aronsen, Laura A Fields, Luisa Mancuso, Giuliano Dodoni, Alessandra Stangherlin, Craig Livie, He Jiang, Yuan Yan Sin,[...]. Circ Res 2015
66
46

Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease.
Dong I Lee, Guangshuo Zhu, Takashi Sasaki, Gun-Sik Cho, Nazha Hamdani, Ronald Holewinski, Su-Hyun Jo, Thomas Danner, Manling Zhang, Peter P Rainer,[...]. Nature 2015
170
34




cGMP signals modulate cAMP levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes.
Alessandra Stangherlin, Frank Gesellchen, Anna Zoccarato, Anna Terrin, Laura Ashley Fields, Marco Berrera, Nicoletta Concetta Surdo, Margaret Anne Craig, Godfrey Smith, Graham Hamilton,[...]. Circ Res 2011
105
29

Advances in targeting cyclic nucleotide phosphodiesterases.
Donald H Maurice, Hengming Ke, Faiyaz Ahmad, Yousheng Wang, Jay Chung, Vincent C Manganiello. Nat Rev Drug Discov 2014
387
29

Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes.
Liliana R V Castro, Ignacio Verde, Dermot M F Cooper, Rodolphe Fischmeister. Circulation 2006
196
27

Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias.
Stephan E Lehnart, Xander H T Wehrens, Steven Reiken, Sunita Warrier, Andriy E Belevych, Robert D Harvey, Wito Richter, S-L Catherine Jin, Marco Conti, Andrew R Marks. Cell 2005
323
27

Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation.
Viacheslav O Nikolaev, Alexey Moshkov, Alexander R Lyon, Michele Miragoli, Pavel Novak, Helen Paur, Martin J Lohse, Yuri E Korchev, Sian E Harding, Julia Gorelik. Science 2010
335
27

Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on beta-adrenergic cAMP signals.
Aniella Abi-Gerges, Wito Richter, Florence Lefebvre, Philippe Mateo, Audrey Varin, Christophe Heymes, Jane-Lise Samuel, Claire Lugnier, Marco Conti, Rodolphe Fischmeister,[...]. Circ Res 2009
74
28

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.
Eiki Takimoto, Hunter C Champion, Manxiang Li, Diego Belardi, Shuxun Ren, E Rene Rodriguez, Djahida Bedja, Kathleen L Gabrielson, Yibin Wang, David A Kass. Nat Med 2005
624
26

Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.
Clint L Miller, Masayoshi Oikawa, Yujun Cai, Andrew P Wojtovich, David J Nagel, Xiangbin Xu, Haodong Xu, Vince Florio, Sergei D Rybalkin, Joseph A Beavo,[...]. Circ Res 2009
109
25

Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure.
Bo Ding, Jun-Ichi Abe, Heng Wei, Qunhua Huang, Richard A Walsh, Carlos A Molina, Allan Zhao, Junichi Sadoshima, Burns C Blaxall, Bradford C Berk,[...]. Circulation 2005
135
25

Phosphodiesterase type 3A regulates basal myocardial contractility through interacting with sarcoplasmic reticulum calcium ATPase type 2a signaling complexes in mouse heart.
Sanja Beca, Faiyaz Ahmad, Weixing Shen, Jie Liu, Samy Makary, Nazari Polidovitch, Junhui Sun, Steven Hockman, Youn Wook Chung, Matthew Movsesian,[...]. Circ Res 2013
80
24

Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases.
Rodolphe Fischmeister, Liliana R V Castro, Aniella Abi-Gerges, Francesca Rochais, Jonas Jurevicius, Jérôme Leroy, Grégoire Vandecasteele. Circ Res 2006
260
24

Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Eiki Takimoto, Diego Belardi, Carlo G Tocchetti, Susan Vahebi, Gianfrancesco Cormaci, Elizabeth A Ketner, An L Moens, Hunter C Champion, David A Kass. Circulation 2007
118
24

Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions.
Sharron H Francis, Mitsi A Blount, Jackie D Corbin. Physiol Rev 2011
355
22

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
Margaret M Redfield, Horng H Chen, Barry A Borlaug, Marc J Semigran, Kerry L Lee, Gregory Lewis, Martin M LeWinter, Jean L Rouleau, David A Bull, Douglas L Mann,[...]. JAMA 2013
678
22

Phosphodiesterase 2 Protects Against Catecholamine-Induced Arrhythmia and Preserves Contractile Function After Myocardial Infarction.
Christiane Vettel, Marta Lindner, Matthias Dewenter, Kristina Lorenz, Constanze Schanbacher, Merle Riedel, Simon Lämmle, Simone Meinecke, Fleur E Mason, Samuel Sossalla,[...]. Circ Res 2017
29
62


Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility.
Jayan Nagendran, Stephen L Archer, Daniel Soliman, Vikram Gurtu, Rohit Moudgil, Alois Haromy, Chantal St Aubin, Linda Webster, Ivan M Rebeyka, David B Ross,[...]. Circulation 2007
346
21

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.
M Packer, J R Carver, R J Rodeheffer, R J Ivanhoe, R DiBianco, S M Zeldis, G H Hendrix, W J Bommer, U Elkayam, M L Kukin. N Engl J Med 1991
20

Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling.
Viacheslav O Nikolaev, Moritz Bünemann, Eva Schmitteckert, Martin J Lohse, Stefan Engelhardt. Circ Res 2006
229
20

cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
Eiki Takimoto, Hunter C Champion, Diego Belardi, Javid Moslehi, Marco Mongillo, Evanthia Mergia, David C Montrose, Takayoshi Isoda, Kate Aufiero, Manuela Zaccolo,[...]. Circ Res 2005
148
20

Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
Ruwan K Perera, Julia U Sprenger, Julia H Steinbrecher, Daniela Hübscher, Stephan E Lehnart, Marco Abesser, Kai Schuh, Ali El-Armouche, Viacheslav O Nikolaev. Circ Res 2015
50
32

Cyclic GMP regulation of the L-type Ca(2+) channel current in human atrial myocytes.
G Vandecasteele, I Verde, C Rücker-Martin, P Donzeau-Gouge, R Fischmeister. J Physiol 2001
104
18

In vivo model with targeted cAMP biosensor reveals changes in receptor-microdomain communication in cardiac disease.
Julia U Sprenger, Ruwan K Perera, Julia H Steinbrecher, Stephan E Lehnart, Lars S Maier, Gerd Hasenfuss, Viacheslav O Nikolaev. Nat Commun 2015
69
21



Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice.
Peter Pokreisz, Sara Vandenwijngaert, Virginie Bito, An Van den Bergh, Ilse Lenaerts, Cornelius Busch, Glenn Marsboom, Olivier Gheysens, Pieter Vermeersch, Liesbeth Biesmans,[...]. Circulation 2009
129
17


Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension.
Kristen J Bubb, Sarah L Trinder, Reshma S Baliga, Jigisha Patel, Lucie H Clapp, Raymond J MacAllister, Adrian J Hobbs. Circulation 2014
34
41


Overview of PDEs and their regulation.
Kenji Omori, Jun Kotera. Circ Res 2007
451
16

Conserved expression and functions of PDE4 in rodent and human heart.
Wito Richter, Moses Xie, Colleen Scheitrum, Judith Krall, Matthew A Movsesian, Marco Conti. Basic Res Cardiol 2011
77
16

Phosphodiesterase 8A (PDE8A) regulates excitation-contraction coupling in ventricular myocytes.
Enrico Patrucco, Masami Shimizu Albergine, Luis F Santana, Joseph A Beavo. J Mol Cell Cardiol 2010
57
22

Phosphodiesterase 4B in the cardiac L-type Ca²⁺ channel complex regulates Ca²⁺ current and protects against ventricular arrhythmias in mice.
Jérôme Leroy, Wito Richter, Delphine Mika, Liliana R V Castro, Aniella Abi-Gerges, Moses Xie, Colleen Scheitrum, Florence Lefebvre, Julia Schittl, Philippe Mateo,[...]. J Clin Invest 2011
71
18

Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
16

Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart.
Clint L Miller, Yujun Cai, Masayoshi Oikawa, Tamlyn Thomas, Wolfgang R Dostmann, Manuela Zaccolo, Keigi Fujiwara, Chen Yan. Basic Res Cardiol 2011
67
17


Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance.
Frank G Boess, Martin Hendrix, Franz-Josef van der Staay, Christina Erb, Rudy Schreiber, Wilma van Staveren, Jan de Vente, Jos Prickaerts, Arjan Blokland, Gerhard Koenig. Neuropharmacology 2004
210
15


Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases.
Marco Mongillo, Theresa McSorley, Sandrine Evellin, Arvind Sood, Valentina Lissandron, Anna Terrin, Elaine Huston, Annette Hannawacker, Martin J Lohse, Tullio Pozzan,[...]. Circ Res 2004
267
15

What is the role of beta-adrenergic signaling in heart failure?
Martin J Lohse, Stefan Engelhardt, Thomas Eschenhagen. Circ Res 2003
473
15

Transgenic mice for real-time visualization of cGMP in intact adult cardiomyocytes.
Konrad R Götz, Julia U Sprenger, Ruwan K Perera, Julia H Steinbrecher, Stephan E Lehnart, Michaela Kuhn, Julia Gorelik, Jean-Luc Balligand, Viacheslav O Nikolaev. Circ Res 2014
39
30

PDE2-mediated cAMP hydrolysis accelerates cardiac fibroblast to myofibroblast conversion and is antagonized by exogenous activation of cGMP signaling pathways.
C Vettel, S Lämmle, S Ewens, C Cervirgen, J Emons, A Ongherth, M Dewenter, D Lindner, D Westermann, V O Nikolaev,[...]. Am J Physiol Heart Circ Physiol 2014
30
40

Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels.
Rodolphe Fischmeister, Liliana Castro, Aniella Abi-Gerges, Francesca Rochais, Grégoire Vandecasteele. Comp Biochem Physiol A Mol Integr Physiol 2005
90
13

PDEs create local domains of cAMP signaling.
Delphine Mika, Jérôme Leroy, Grégoire Vandecasteele, Rodolphe Fischmeister. J Mol Cell Cardiol 2012
81
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.